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The arginine-vasopressin (AVP)-containing hypothalamic magnocellular neurosecretory
neurons (VPMNNs) are known for their role in hydro-electrolytic balance control
via their projections to the neurohypophysis. Recently, projections from these same
neurons to hippocampus, habenula and other brain regions in which vasopressin
infusion modulates contingent social and emotionally-affected behaviors, have been
reported. Here, we present evidence that VPMNN collaterals also project to the
amygdaloid complex, and establish synaptic connections with neurons in central
amygdala (CeA). The density of AVP innervation in amygdala was substantially
increased in adult rats that had experienced neonatal maternal separation (MS),
consistent with our previous observations that MS enhances VPMNN number in the
paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus. In the CeA,
V1a AVP receptor mRNA was only observed in GABAergic neurons, demonstrated
by complete co-localization of V1a transcripts in neurons expressing Gad1 and
Gad2 transcripts in CeA using the RNAscope method. V1b and V2 receptor mRNAs
were not detected, using the same method. Water-deprivation (WD) for 24 h, which
increased the metabolic activity of VPMNNs, also increased anxiety-like behavior
measured using the elevated plus maze (EPM) test, and this effect was mimicked by
bilateral microinfusion of AVP into the CeA. Anxious behavior induced by either WD
or AVP infusion was reversed by CeA infusion of V1a antagonist. VPMNNs are thus
a newly discovered source of CeA inhibitory circuit modulation, through which both
early-life and adult stress coping signals are conveyed from the hypothalamus to the
amygdala.
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INTRODUCTION
Arginine-vasopressin (AVP)-containing magnocellular
neurosecretory neurons (VPMNNs) have a critical role in
the control of water-electrolyte balance via AVP release from
the neurohypophysis, and also influence fundamental behaviors
important for survival, presumably at the level of the brain
itself (Greving, 1923, 1928; Harris, 1948; de Wied, 1979; Koob
et al., 1981; Landgraf and Neumann, 2004). However, despite
the profound behavioral and physiological effects of central
AVP (Mühlethaler et al., 1982; Landgraf and Neumann, 2004),
and early attempts to characterize the central projections of
the VPMNN (Buijs, 1978, 1980; DeVries et al., 1985), we
remain relatively uninformed about the central organization of
the underlying AVP neuronal connections within the central
nervous system (CNS): i.e., physiological circuit interactions,
synaptic innervation patterns, and the identity of post-synaptic
neuronal targets.
One area of the brain in which AVP likely exerts profound
behavioral effects is the amygdala. The amygdala is a complex
structure involved in anxiety and fear processing (Davis and
Whalen, 2001; LeDoux, 2007). In particular, the central amygdala
(CeA) is thought to be critical for emotional processing
of environmental input, especially in regard to plasticity of
behavioral responses to stress (Penzo et al., 2015). A potential
target for AVP input to CeA are its numerous GABAergic
neurons (Sun and Cassell, 1993; Swanson and Petrovich, 1998),
which are important for expression of anxiogenic responses (Sun
et al., 1994; Pará et al., 2004; Huber et al., 2005).
There are well-documented AVP projections to amygdala
(Buijs, 1978, 1980; Buijs and Swaab, 1979; Buijs et al., 1983; Caffé
and van Leeuwen, 1983; Rood and De Vries, 2011; Zhang and
Hernández, 2013), and AVP elevation in CeA is correlated with
maternal aggression and other stress-related behaviors (Landgraf
and Neumann, 2004). However, the origin, distribution, and
co-localization with classical neurotransmitters of these fibers,
and behavioral consequences of activation of AVP release from
these fibers, especially during development, have received little
attention. In particular, it has only been demonstrated recently
that dynamic regulation of VPMNNs of the hypothalamic
paraventricular (PVN) and supraoptic (SON) nuclei may
convey stressor response signals to non-neurohypophyseal
limbic regions (Hernández and Zhang, 2012; Zhang et al.,
2012; Zhang and Hernández, 2013; Hernández et al., 2015).
Thus, we have now begun to characterize the VP-MNN
projections to the amygdala, and investigate their involvement
in developmentally-related and adult stress responses.
Perinatal stress in rodents, such as maternal separation
(MS), fragmented maternal care, and maternal endocrine
dysfunction, has been used to examine the causal relationship
between early life stress and later stress overreactivity and
susceptibility to affective disorders (Zhang et al., 2010, 2012;
Lukas et al., 2011). AVP is among several neurotransmitter
systems reported to be altered as a consequence of early life stress
(Veenema et al., 2006, 2007; Lukas et al., 2011), and therefore
is among the neurotransmitter candidates for mediating the
reported later-life behavioral hyperreactivity associated with
early life stress. We have reported that the AVP system is
activated as a consequence of stress during the early life
period, with increased VPMNN PVN and SON cell number,
enlargement of Herring body densities, and increased number
of reciprocal synaptic connections between vasopressinergic and
corticotropin releasing factor (CRF) containing neurons. This
neuronal plasticity is associated with increased sensitivity to
acute stressors, and anxiogenic conditions in adulthood (Zhang
et al., 2010, 2012).
In the present study, we have combined
immunohistochemistry with antero- and retrograde tracing,
electron microscopy and anatomical analysis, to show that
AVP innervation of the amygdaloid complex has at least dual
origins: thin fibers likely arising from a small population
of neurons localized in the bed nucleus of stria terminalis
intra-amygdaloid division (STIA), likely to establish Gray type
II synapses; and thick fibers originating from hypothalamic
PVN and SON, positive for vGluT2 and establishing Gray type
I synapses. Semiquantitative anatomical analysis in combination
with AVP-IHC showed that the medial amygdala (MeA)
was the region with the densest AVP innervation followed
by the rostral part of the CeA, where V1a receptor-positive
GABAergic neurons were located. MS produced a substantial
increase in AVP immunopositive fibers, especially in the central
and medial amygdala. We also found that in the CeA the
V1a receptors were only expressed in GABAergic neurons.
Finally, physiological and pharmacological manipulations of
vasopressinergic neurotransmission from PVN to CeA were
used to show the functional importance of this projection
to the modulation of anxious behavior in the rat. In this
regard, we examined the effects on vasopressinergic projections
from the hypothalamic VPMNNs to the amygdala, of at
least one physiological condition, water deprivation (WD),
for which neurohypophyseal AVP (hormone) release is
a known homeostatic response, in order to determine if
there is a corresponding allostatic response to WD in the
amygdala. Here, we report that this is indeed the case, and
discuss its implications for dual vasopressinergic homeostatic
regulation via the neurohypophysis, and allostatic regulation via
VPMNN projections to extrahypothalamic brain, including the
amygdala.
MATERIALS AND METHODS
Animals
Adult male Wistar rats of 280 ± 20 g were obtained from the
local animal facility. Animals were housed three per cage under
controlled temperature and illumination (12 h/12 h, inverted to
the natural light/dark cycle) with water and food ad libitum.
All animal procedures were approved by the Comision de
investigacion y Etica de la Facultad de Medicina, Universidad
Nacional Autonoma de Mexico (approval number: CIEFM-086-
2013).
Maternal Separation Protocol
The MS (3 h daily, MS 3 h) procedure is described
in detail elsewhere (Zhang et al., 2012). Briefly, female
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and male adult rats were mated for 2 days. During the
last week of gestation, female rats were single-housed in
standard rat Plexiglas cages and maintained under standard
laboratory conditions. On the day after parturition, postnatal
day (PND) 2, each litter was culled to 7–8 pups, in which
5–6 were males. During the period from PND 2–PND 16,
the pups were separated daily from their dams, and placed
into an incubator at 29◦C ± 1◦C, between 09:00 h and
12:00 h. After this period rats were returned to their
home cages. After ending the MS protocol, animals were
left undisturbed until the weaning at PND 28, when male
and female rats were separated. Animals were then left
undisturbed until PND 90 when the elevated plus maze
(EPM) was performed during their activity period. Animal
facility reared (AFR) rats were treated in the same conditions
as described above except that these animals were left
undisturbed in their cages during the period when MS 3 h
rats were separated from their dam. Bedding was changed
twice a week for both groups, with minimum disturbance to
the rats.
Immunohistochemistry
Rats were deeply anesthetized with an overdose of sodium
pentobarbital (63 mg/kg, Sedalpharma, México) and perfused
transaortically with 0.9% saline followed by cold fixative
containing 4% of paraformaldehyde in 0.1 M sodium phosphate
buffer (PB, pH 7.4) plus 15% v/v saturated picric acid for
15 min (for the immunoreaction using monoclonal antibody
against GABA, 0.1% glutaraldehyde was also added to the
fixative solution). Brains were immediately removed, blocked,
and then thoroughly rinsed with PB. Brains were sectioned
soon after perfusion using a Leica VT 1000S vibratome.
Freshly-cut freely-floating sections were blocked with 20%
normal donkey serum (NDS) in Tris-buffered (0.05 M, pH 7.4)
saline (0.9%) plus 0.3% of Triton X-100 (TBST) for 1 h at room
temperature and incubated with the primary antibodies listed
in Table 1 (for antibody specificity see ‘‘Supplementary Material
Table S1’’). For light microscopical immunohistochemistry,
Vectastain Elite ABC Kit was used (Vector Labs, Burlingame,
CA, USA) followed by DAB-peroxidase reaction, while for
immunofluorescence reactions, sections were incubated
with the corresponding fluorochrome-conjugated secondary
antibodies. For immunoreaction visualization, a Nikon Eclipse
50i light microscope and a Leica TCS-SP5 confocal microscope
were used.
Anatomical Assessment of AVP Innervation
Density in Amygdala Subfields and
Comparison Between MS and AFR Rats
Observations were made under light microscopy. Anatomical
nomenclature, especially on amygdala subfields, and regional
delineation were according to Paxinos and Watson (2006). To
evaluate the densities of vasopressin-containing axon projections
in amygdala, observations were made under a light microscope
(Nikon Eclise, 50i, with 40× objective) and tracing was
performed with the help of a drawing tube attached to the
microscope (amplification at 10.6×). A square equivalent to
0.04 mm2 of the brain tissue section was placed under the
drawing tube projecting to the visual field coinciding with
the anatomical regions of interests. AVPir+ fibers inside the
projected square were manually traced. Calculation of fiber
length in each square was performed using ImageJ (open
image > make binary > measure). The value of the area in
the results window corresponds to the number of pixels in
the image. Since the process of skeletonization converts every
trace into a one pixel thick trace, the number of pixels equals
the summed length of the traces in pixels. The real length is
converted to millimetre taking into account the correspondence
between pixels and a known scale value. AVPir+ fiber length
from postero-dorsal medial amygdala (MePD) from coronal
section (Bregma. −2.7 mm) was 3618 mm and was assigned
as 100%. Fiber lengths falling in the range of 100%–76% were
assigned as ++++; 75–51% as +++; 50–26%: as ++ and 25–1% +.
Neuronal Activation Through
Fos-Expression Assessment
The pattern of amygdala neuronal activation after the EPM test
was evaluated in four animals for each of the cannulated rat
groups, i.e., those infused with NaCl 0.9%, with AVP 1 ng, or
with AVP 1 ng + V1a antagonist 10 ng. The number of Fos+
nuclei in an area of 0.2 mm2 was counted in the central (CeA),
basolateral (BLA) and MeA, around Bregma −2.12 mm. A two
way analysis of variance (ANOVA) was used to evaluate if the
differences between the NaCl, AVP 1 ng and AVP 1 ng + V1a
antagonist groups were statistically significant.
Immunohistochemistry for Transmission
Electron Microscopy (TEM)
Immuno-electron microscopy procedures were performed as
reported previously (Zhang and Hernández, 2013). Briefly,
TABLE 1 | Primary antibodies used in this study.
Molecule Host Dilution Source Source code
[Arg8]-vasopressin Rabbit 1:5000 Peninsula-Bachem Americas, Inc., CA, USA (www.bachem.com) T-4563
[Arg8]-vasopressin Rabbit 1:2000 Prof. R.M. Buijs, Instituto de Investigaciones Biomédicas, Universidad
Nacional Autónoma de México, UNAM
–
c-Fos Rabbit 1:2000 Santa Cruz Biotechnology, Dallas, TX, USA (www.scbt.com) SC-52
Vesicular glutamate transporter 2 Guinea pig 1:1000 Frontier Institute Co., Ltd., Hokkaido, Japan (www.frontier-institute.com) GP-AF240-1
Gamma-aminobutyric Acid (GABA) Mouse 1:1000 Sigma-Aldrich Corporation, St. Louis, MO, USA
(www.sigmaaldrich.com)
A031
Vasopressin V1A Receptor Rabbit 1:2000 Alomone Labs., Jerusalem, Israel (www.alomone.com/) AVR-010
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FIGURE 1 | Distribution of vasopressin-immunostained fibers through the rostrocaudal extent of amygdala in the rat. Low (A–K) and high power
(Aa–Ka) photomicrographs and tracings of arginine-vasopressin (AVP) labeled fibers (Ab–Kb) in coronal sections, illustrating the heterogeneous distribution in the
density of AVP fibers among different amygdalar regions. The highest density was found in the MePD region at Bregma level −2.70 mm (panel I, and table). Each of
the panels from (A–K) corresponds to a representative example at the bregma level indicated in the table gray boxes. For the semiquantitative analysis in the table,
the summed length (calculated with ImageJ) of fibers in a 0.04 mm2 area, inside this highest density region was assigned as 100%, regions with summed lengths
between 76–100% were assigned as ++++; between 51–75% : +++; between 26–50%: ++ and between 1–25%: +.
(Continued)
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FIGURE 1 | Continued
Anatomical maps and nuclei nomenclature are from the rat atlas of Swanson
(2003). CxA, cortico-amygdalar transition zone; AA, anterior amygdala area;
Aco, anterior-cortical amygdaloid nucleus; MeA, medial anterior amygdaloid
nucleus; BMA, basomedial anterior amygdaloid nucleus; CeA, central nucleus
of amygdala; BLA, basolateral amygdala; STIA, stria terminalis
intra-amygdaloid division; MePD, medial postero-dorsal amygdaloid nucleus;
MePV, medial postero-ventral amygdaloid nucleus; BMP, basomedial posterior
amygdaloid nucleus. Scale bars in (Aa–Ka, Ab–Kb) 50 µm, Bregma levels are
indicated below each low power photomicrograph. Squared region indicates
the 200 µm area used for calculation of summed length for each amygdala
region.
two male rats were perfused with NaCl 0.9%, and fixed
with ice-cold 4% paraformaldehyde (Sigma P6148) + 15% v/v
saturated picric acid solution (Fermont) + 0.05% glutaraldehyde
(Sigma, G5882). Sections 70 µm-thick containing CeA were
processed with conventional IHC for TEM (Zhang and
Hernández, 2013). Sections were then osmificated in 1%
OsO4 for 1 h and dehydrated in a graded series of ethanol
and embedded in synthetic resin (Epon). Ultrathin sections
were then cut, counterstained with lead citrate (Electron
Microscopy) and examined with a Philips CM 100 transmission
electronmicroscope and photographed with a digital micrograph
3.4 camera (Gatan Inc., Pleasanton, CA, USA).
Fluoro-Gold Tracing Experiments
Anesthesia was induced and maintained with xylazine (Procin,
Mexico; 20 mg/ml) and ketamine (Inoketam, Virbac, Mexico;
100 mg/ml) mixed in a 1:1 volume ratio and administered
intramuscularly with a dose of 1 ml/kg body weight. Rats
were fixed in a stereotaxic apparatus and were injected in the
CeA (Bregma −2.12 mm, medio-lateral 4.2 mm, dorsoventral
7.7 mm (Paxinos and Watson, 2006)) with the retrograde
tracer Fluoro-Gold (FG, Fluorochrome, LLC, Denver, CO, USA),
dissolved 1% in 0.2 M sodium cacodylate buffer (pH 7.5).
The FG was delivered iontophoretically using an iontophoresis
pump (Value Kation Sci VAB-500) through a stereotaxically
positioned glass micropipette with an inner tip diameter of
approximately 40 µm, by applying current pulses of 0.1 µA, at
0.2 Hz, with a 50% duty cycle, for 20 min. The micropipette
was left in place for an additional 10 min to prevent backflow
of the tracer up the injection track after each injection. After
completing the surgery, rats received 0.4 mg/kg i.p. Ketorolac
(Apotex, Mexico) and 50 mg/kg i.p ceftriaxone (Kendric,
Mexico) as analgesic/anti-inflammatory and antibiotic agents,
respectively. Three to four weeks after the FG injections,
the rats were perfused as previously described (Zhang and
Hernández, 2013). Coronal and sagittal sections of 70 µm
were obtained, and AVP IHC was performed to evaluate if
the SON and PVN AVP+ neurons were labeled with FG.
Observations were made under light (Nikon ECLIPSE 50i with
B-2A long-pass emission filter) and confocal microscopy (Leica
TCS-SP5).
ISH Assays With Radio-Probes
Rats were deeply anesthetized with sodium pentobarbital
(Sedalpharma, México, 63 mg/kg b.w., i.p.) and perfused via
ascending aorta with 0.9% saline followed by cold fixative
containing 4% paraformaldehyde in 0.1 M PB, pH 7.4. Brains
were post-fixed with 1% paraformaldehyde in PB and kept at
4◦C until use. All solutions used had been diethyl pyrocarbonate
(DEPC)-treated (0.1% v/v with gentle stirring for at least 4 h at
room temperature) to inactivate any residual RNase, and then
autoclaved to inactivate the traces of DEPC.
Two days before the start of sectioning, the brains were
moved to 18% sucrose in RNase free PB + NaN3. Another
change was done 1 day before the sectioning and a third
change with a fresh sucrose solution was done 1 h before the
sectioning. Serial coronal sections between Bregma −0.36 mm
and Bregma −3.00 mm of 12 µm of thickness were made using
a Leica CM1950 cryostat (Leica Microsystem, Wetzlar, 35578,
Germany). Sections were collected on Leica glass insert and then
transferred to a 24-well tissue culture plate with PB.
In situ hybridization (ISH) was performed in one out of six
coronal sections as previously described (Morales and Bloom,
1997) using 35S- and 33P-UTP-labeled ribonucleotide probes.
The pT7T3D-PacI plasmid (accession number: AI072073, clone
ID: 1786383 Thermo Scientific) containing rat vasopressin
receptor V1a cDNA (Morel et al., 1992) was linearized with
EcoRI and then transcribed in vitro with T3 RNA polymerase
to yield antisense complementary RNA probe. The construct was
verified by sequencing. The radioactivity was adjusted to 107 cpm
per ml hybridization buffer. Sections were mounted on coated
slides and air-dried. Slides were exposed to autoradiography
film and analyzed on a phosphorimager (Fuji BAS5000, Tokyo,
Japan).
RNAscope ISH Assays
Two rats were deeply anesthetized and perfused via the
ascending aorta with saline. Whole brain tissues were
removed and rapidly frozen on Dry Ice. The fresh-frozen
tissue sections (thickness: 20 µm) were mounted on positively
charged microscopic glass slides (Fisher Scientific, Pittsburgh,
PA, USA). The Gad1, Gad2 and V1a specific RNA probes
(Rn-Gad1, 316401-C1; Rn-Gad2, 435801-C2; Rn-Avp1a,
402531-C3) were designed and provided by Advanced Cell
Diagnostics (Hayward, CA, USA). All staining steps were
performed following RNAscope protocols. Stained slides were
cover-slipped with fluorescent mounting medium (ProLong
Gold Antifade Reagent P36930; Life Technologies, Carlsbad,
CA, USA) and examined with a confocal microscope (Leica
TCS-SP5).
Intra-Amygdaloid Microinjection
For the implantation of permanent guide cannulas into the
amygdala, rats were anesthetized with ketamine hydrochloride
(170 mg/kg, i.p.) and placed in a stereotaxic frame (Kopf
Instruments, Tujunga, CA, USA) with the incisor bar set
at −3.3 mm. Body temperature was maintained at 37◦C
using a CMA/150 temperature controller (CMA/Microdialysis,
Stockholm, Sweden). Bilateral stainless steel cannulae of 0.46mm
outer diameter (C315G, Plastics One, Roanoke, VA, USA) were
aimed to CeA (Bregma −1.7 mm, mediolateral ± 4.2 mm,
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FIGURE 2 | Anatomo-immunohistochemical features of vasopressin immuno-reactive (AVPir) somata and fibers in the amygdaloidal complex
suggest that AVP modulates distinct neuronal circuits. (A) Photomicrograph of AVPir in a sagittal section of rat amygdala at lateral 3.40 mm (Aa, inset: sagittal
view of amygdaloid complex, squared region, from the Rat Brain Atlas). Note that the AVP immunopositive fibers (indicated by black arrows) are heterogeneously
distributed in the whole amygdala complex and numerous AVP+ cells were inside the bed nucleus of stria terminalis, intra-amygdaloid division (STIA; circumscribed
with white dashed line). (Ab) Amplification of a region inside the STIA. Note that there are two types of AVPir+ fibers, regarding their thickness and spatial frequency
of varicosities: the type I fibers have thick diameter and frequent varicosities (thick white arrows); the type II fibers are thin and had less frequent varicosities (thin
white arrows). Both types are intermingled in the same region. The asterisk indicates the site where one thin-type axon (the axon initial segment was indicated with
(Continued)
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FIGURE 2 | Continued
a hollow arrow, white in both (Ab) and its inset) originated (asterisk) from one
proximal dendrite of the respective neuron. (B) A semi-horizontal section of rat
brain showing the vicinity of the hypothalamic AVP+ supraoptic (SON) and
paraventricular (PVN) nuclei and the massive projection of AVPir fibers toward
amygdala and amygdala-hippocampal cortex (AHiCtx; white arrowheads in
Ba,Bb). The red line of the atlas inset symbolizes the level and the inclination of
the section plan. (Ba) Amplification of the corresponding squared region
showing the SON is seen from the semi-horizontal view. (Bb) Amplification of
the corresponding squared region of amygdaloid complex. Note the
heterogeneous presence of the AVPir fibers in the amygdaloid subdivisions.
MeApd, medial amygdala postero-dorsal; CeA, central amygdala; BLA,
basolateral amygdala. Scale bars: (A) 500 µm; (Ab) and Inset: 20 µm;
(B) 500 µm; (Ba) 100 µm; (Bb) 100 µm.
dorsoventral −7.7 mm from skull surface, according to the
atlas of Paxinos and Watson (2006). Guide cannulas were
fixed with stainless-steel screws and dental acrylic cement
(Laboratorios Arias, Mexico City, Mexico) and sealed with
dummy cannulae (C315DC, Plastics One). Benzylpenicillin
benzathine (Estrepto benzetacil V-Fortificado (Fort Dodge
Animal Health Laboratories, Mexico City, Mexico)) was given to
prevent infection. The animals were housed in individual cages
post-surgery. A total of 30 rats were employed for microinjection
experiments.
Beginning on the fourth day post-surgery, rats were handled
once a day for 5 min for three consecutive days, and
behavioral tests were performed the next day (seventh day post-
surgery).
On the day of the experiment, saline alone (250 nl per
side), AVP (Sigma V9879, 1 ng in 250 nl per side of NaCl
0.9%, (Appenrodt and Schwarzberg, 2000) or V1a antagonist
(d(CH2)5 1, Tyr(Me) 2, Arg8)-Vasopressin trifluoroacetate salt,
Manning compound; 10 ng in 250 nl per side), depending the
experimental groups, were injected bilaterally via an injection
cannula (0.20 mm outer diameter, C315I, Plastics One), which
protruded 1 mm beyond the end of the guide cannula,
over a period of 5 min (Pérez de la Mora et al., 2006),
using two CMA/Microdialysis pumps (CMA/Microdialysis,
Stockholm, Sweden). The cannulae were kept in place for
1 min after the injection to prevent backflow and to allow for
diffusion. Behavioral observations were started 15 min after
microinjections.
Elevated Plus Maze
The EPM was made locally (for details see Zhang et al., 2010,
2012). The test was performed during the early activity period
under dim red light and video recorded. Briefly, testing is
performed by placing the rat in the center of the maze facing
towards an open arm, and free exploratory activity is observed
for 5 min. An entry into an open arm was counted when the
four paws of the rat were placed within that arm. The time
spent in the open arms, as percentage of total time (300 s), was
analyzed off-line. For each treatment, the person administering
the drug was aware of the animal’s status (i.e., control-reared or
MS-reared). The persons who performed behavioral assessments
were unaware of either the rearing or treatment status of each
assessed animal.
Two sets of experiments (‘‘Experiment 1’’ and
‘‘Experiment 2’’) were performed. Experiment 1: MS (n = 10)
and AFR (n = 10) rats underwent a 24 h water-deprivation
period (WD 24 h) previous to the EPM test. The rationale of
this set of experiments was that WD 24 h potently up-regulates
the metabolic activity of the hypothalamic VPMNNs but with
only a modest increase in plasma osmolarity (Dunn et al., 1973;
Zhang et al., 2012). Moreover, we have previously reported that
MS rats possess a potentiated VPMNN system in adulthood,
with enhanced anxiety state as measured by the Vogel conflict
test, after WD 24 h (Zhang et al., 2012). Experiment 2: three
experimental groups of AFR rats were assessed under EPM
paradigm. Group A: microinjection with saline; group B,
microinjection with AVP and group C, microinjection with AVP
and the V1a specific antagonist.
Statistical Analysis
Quantitative results were expressed as mean ± SEM. Groups
were tested for normality with a D’Agostino and Pearson test.
Differences between means were evaluated by one-way ANOVA
followed by the Bonferroni test. All computations were done
using Prism (GraphPad Software, Version 6, San Diego, CA,
USA). Differences in all cases were considered statistically
significant when P < 0.05.
RESULTS
Anatomical Features of
Arginine-Vasopressin Containing Somata
and Fibers in the Amygdaloidal Complex
as Revealed by Immune-Reaction (AVPir)
We used an AVPir-optimized protocol previously designed by
us (Zhang and Hernández, 2013) to reveal the AVP-containing
fibers and somata distribution. We observed, as shown in
Figure 1, a heterogeneous distribution of fibers in the whole
amygdaloid complex, with the medial MePD, the MeA (rostral
to MePD), the bed nucleus of STIA and the anterior amygdala
(AA, rostral to CeA) being the most densely innervated regions.
AVPir somata were observed in the STIA and surrounding
regions (Figure 2A dashed line circumscribed region). These
cells were sparsely distributed and had pale AVPir labeling.
AVPir + fibers all over amygdala showed either a strong-dark
labeling or a weak-pale labeling pattern. Two kinds of fibers
were observed. The first kind of fiber was varicose, and was
the most frequently observed fiber type (Figure 2Ab). The
second kind was rarer, and less varicose. We will refer to
these as Type I and Type II fibers, respectively, in accordance
with the previous nomenclature that we used for hippocampal
AVP innervation (Zhang and Hernández, 2013). Some type
II axon proximal segments could be found leaving AVPir
somata (Figure 2Ab inset). Using semi-horizontal sections, we
could clearly appreciate the limits between the hypothalamic
PVN, SON and amygdala. Figures 2Bs show the massive
projection and the heterogeneous distribution patterns
of AVPir fibers towards amygdala/amygdalo-hippocampal
cortex.
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FIGURE 3 | Continued
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FIGURE 3 | Anatomical charting of AVPir+ fiber distribution in amygdala in both control (A–J) and maternal separation (MS) male adult rat (MS, A’–J’).
Chartings of coronal sections at 10 rostro-caudal levels with line drawings referenced with microscopic observation, representing AVP fiber distribution through the
entire amygdaloidal complex. Note the remarkable increase in AVP innervation densities in all regions of the amygdala as a function of MS.
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TABLE 2 | Vasopressin fiber density distribution in animal facility reared
(AFR) and MS rats.
Control Maternal separation
Bregma BLA CeA MeA Bregma BLA CeA MeA
(mm) (mm)
−1.72 + ++ +++ −1.72 + ++ ++++
−1.86 + ++ +++ −1.86 + ++ ++++
−2 + ++ +++ −2 + ++ ++++
−2.14 − + +++ −2.14 + ++ ++++
−2.28 + + +++ −2.28 + ++ ++++
−2.42 + + +++ −2.42 + ++ ++++
−2.56 − + +++ −2.56 ++ + ++++
−2.7 − + +++ −2.7 ++ + ++++
−2.84 + + +++ −2.84 ++ ++ ++++
−2.98 + ++ +++ −2.98 ++ + ++++
Tracing was performed under camera lucida and calculation of axonal length in a
determined region was calculated using ImageJ. Axon length value from Medial
Amygdala (MeA) at Bregma level −1.86 mm in maternal separation (MS), was
asigned to 100% (++++) = MAX value. For each region, ++++, +++, ++ and +
semi-quantitative values were assigned for fiber length values 76–100%, 51–75%,
26–50% and 1–25% of the MAX value.
Effect of Maternal Separation on Density
of AVP Innervation in Amygdala
The density of AVP innervation in amygdala was substantially
increased in adult rats who had experienced neonatal MS,
consistent with our previous observations that MS enhances
VPMNN number in the PVN and SON nuclei of the
hypothalamus. Using anatomical analysis with the help
of light microscope and a drawing tube, we produced a
coordinate-detailed anatomical chartings of AVP innervation
in adult male rat amygdala (Figures 3A–J). The density of AVP
innervation in amygdala was substantially increased in adult rats
that had experienced neonatal MS (Figures 3A’–J’ and Table 2),
consistent with our previous observations that MS enhances
VPMNN number in the PVN of the hypothalamus.
Immuno-Electron Microscopical Evidence
of Synaptic Innervation by Thick and Thin
AVP-Containing Fibers onto Central
Amygdala (CeA) Neurons, Establishing
either Gray Type I (Asymmetric; Thick) or
Gray Type II (Symmetric; Thin) Synapses
Ultrastructural analysis of the AVP innervation showed
that thin and thick AVP immunopositive fibers, with
dense core vesicles (dcv, AVPir+), made synapses onto
dendrites in the CeA. The axon terminals (AT) of the thin
fibers presented pleomorphic clear vesicles characteristic of
GABAergic AT and preferentially made presumptive inhibitory
(GABAergic) symmetric ‘‘Gray type II’’ synapses, while the
thick fibers made presumptive excitatory (glutamatergic)
asymmetric ‘‘Gray type I’’ synapses (Figures 4A–D). To
further confirm the excitatory nature of the thick fibers in
amygdala, double immunohistochemistry against AVP and
the vesicular glutamate transporter (VGLUT2) was performed.
Confocal microscopical analysis in the CeA showed that thick
varicose axonal fibers containing AVP co-expressed VGLUT2
(Figures 4E–H).
Anterograde and Retrograde Tracing
Revealed that PVN and SON Magnocellular
Vasopressinergic Neurons Innervate the
Central Amygdala
The presence of two AVP+ fiber populations, with distinct
diameters and synaptic profiles, suggested that the AVP
innervation in amygdala could have different origins. To assess
this, fluorogold (FG) was stereotaxically injected in the CeA.
Three to four weeks following the FG injection, rats were
perfused, brains were sectioned, immunohistochemistry against
vasopressin was performed, and areas of interest were evaluated
under a confocal microscope. Cases in which the injection area
was sufficiently focused (<500 µm in diameter), and localization
of the injection site to CeA was achieved, were evaluated. A
number of AVP+ neurons in the PVN and SON showed clear FG
labeling, mainly accumulated in the perikarya of lysosome-like
granules (Figures 5B–D), which is a prominent characteristic
reported for successful long-term FG labeling (Schmued and
Fallon, 1986; Wessendorf, 1991; Persson and Havton, 2009).
These results confirmed previous observations of our
group (Hernández et al., 2015), in which some axons of an
in vivo juxtacellularly labeled AVP+ magnocellular neuron
from hypothalamic PVN nucleus, reconstructed under a camera
lucida, were seen reaching the CeA and MeA (Figure 5A).
An Increase in Anxious Behavior Observed
After Water Deprivation of 24 h (WD 24 h)
and Further Significantly Increased in MS
Subjects
Anxiety was assessed using the EPM. To evaluate whether
up-regulation of the VPMNN system could influence anxiety
as measured in the EPM test, and if MS, which had resulted
in a hyper-innervation pattern of AVP in the amygdala, could
further influence anxiety in adults, we performed this behavior
test with the following four groups: AFR basal, MS basal,
AFR with 24 h of WD (AFR WD 24 h) and MS with
24 h of WD (MS WD 24 h; Figure 6). One-way ANOVA
showed that the differences between means were statistically
significant (p < 0.001, F(3,36) = 26.44). Post hoc Bonferroni’s
multiple comparisons test showed that under basal conditions no
significant difference was seen between the percentage of time
spent in the open arms by the AFR (29.75% ± 3.51%) and MS
(29.13% ± 2.65%) rats (p > 0.05). WD significantly decreased
the time spent in the open arms in both groups (p < 0.001,
when compared with the corresponding basal condition) with
WD 24 h reducing open arm time to 14.08% ± 2.45% in the
AFR group, and to 4.67% ± 0.93% in the MS group. There
was a significantly greater reduction in time spent in open
arm following WD 24 h in the MS, than in the AFR group
(p< 0.001).
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FIGURE 4 | Immuno-electron microscopical evidence of synaptic innervation by thick and thin AVP-containing fibers onto central amygdala (CeA)
neurons, establishing either Gray type I (asymmetric; thick) or Gray type II (symmetric; thin) synapses. Examples of thick axon terminals (AT) (A,B) making
Gray type I synapses (the presence of postsynaptic density, PSD, are indicated by single arrowheads) and thin AT (C,D) making Gray type II synapses (the absence
of PSD are indicated by double arrowhead) onto CeA neurons’ dendrites (Den, pink shaded). Note that the yellow shaded presynaptic active zone of an axon
terminal of a thin fiber contained pleomorphic small clear vesicles, which is a remarkable feature of a GABAergic AT; it also contained AVPir+ dense core vesicle (dcv).
Thick AVPir fibers in the CeA contain vesicular glutamate transporter (VGLUT2)-positive varicosities. Confocal microscopy analysis of CeA showed thick varicose
fibers immunopositive for AVP (E) and multiple VGLUT2-positive terminals (F) with co-expression of VGLUT2 and AVP in a representative thick fiber (G,H). For (G,H),
the x–y (center), x–z (box below) and y–z (right box) images are shown. Scale bars: (A–D) 500 nm; (E–H) 10 µm.
Frontiers in Neural Circuits | www.frontiersin.org 11 November 2016 | Volume 10 | Article 92
Hernández et al. Vasopressinergic Modulation of CeA GABAergic Neurons
FIGURE 5 | AVP-containing magnocellular neurons innervate the CeA. (A) Camera lucida reconstruction of the coronal projection and corresponding
photomicrographs (insets) showing the dendritic and axonal patterns of an anterogradely labeled AVP-containing magnocellular neurosecretory neuron sending axon
collaterals to the medial and CeA. This panel was modified from Hernández et al. (2015), see the original publication for method descriptions. Red, blue and pink
arrows indicate the origins of three parent-axons. Red and blue arrowheads indicate the subsequent axonal branches. The green arrowheads indicate the beaded
processes originated from the dendritic processes, some of them entering the fornix (green arrowheads). Such processes were described in an early study and were
considered as axonal processes (Sofroniew and Glasmann, 1981). (A1a) AVP-containing nature was ascertained by AVP immunoreaction;
(Continued)
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FIGURE 5 | Continued
(A1b) neurobiotin-peroxidase-AB complex histochemical reaction showing the
morphology of the filled AVPir+ neuron’s soma and its three parental axons
emitted from proximal dendrites (pink, red and blue arrows indicate the sites
where the axons were originated). Note that two of those axons were emitted
from the same proximal dendritic point (red and blue arrows but coursed to
opposite directions). (A2) Photomicrograph of the section contiguous caudally
to the section of soma (A1b) showing the branching of the axon collaterals
(colors are aimed to encode each group of collaterals originated from the
same parental main axon). (A3,A4) show axonal processes found in
amygdala. Scale bars: 100 µm for (A) 50 µm for all photomicrographs. MeA,
medial amygdala; CeA, central amygdala; opt, optical tract; fx, fornix.
Panel (B) Fluorogold (FG; retrograde neural tracer) was iontophoretically
injected into CeA. (Cs) panels correspond to the retrograde labeling images of
the PVN with FG, AVPir and overlapping of the two channels respectively.
(C’s) show an example of a magnocellular AVPir+ neuron in high
magnification. Note that the green dots, which correspond to FG, are
peri-nuclear which likely are intra-lisosomal. (D,D’) are the corresponding
images for supraoptic nuclear labeling. Scale bar: 50 µm.
FIGURE 6 | Elevated plus maze (EPM) performance after AVP
magnocellular system upregulation induced by 24-h water deprivation
(WD, 24 h). Under basal conditions, no differences in the time spent in the
open arms were observed between MS and control (animal facility reared,
AFR) rats. One way ANOVA with Bonferroni Post hoc test, showed that
WD 24 h induced a significant reduction in the time spent in the open arm in
both AFR and MS groups (∗∗∗p < 0.001 for WD (24 h) compared to basal, for
each of the two groups AFR and MS). Reduction in time spent in open arms
following WD (24 h) was significantly greater in the MS compared to the AFR
group (∗∗∗p < 0.001).
V1A Receptor mRNA Expression in
Anterior and Central Amygdala
V1a receptor mRNA is strongly expressed in AA and CeA
while V1b and V2 mRNA were not detectable using the
RNAscope method. The V1a mRNA expression had a complete
co-localization with Gad1 and Gad2 mRNA in CeA. Based
on the foregoing findings, we hypothesized that the some or
all the currently identified GPCRs for vasopressin, namely the
V1a, V1b and V2 receptors, were involved in the anxiogenic
action of vasopressin during the WD 24 h. We first successfully
developed a V1a riboprobe based on the procedures of Morel
et al. (1992) and we used the traditional ISH method to examine
the V1a mRNA in the whole amygdaloidal complex (including
rostro-caudal span). Phospho-imager detection showed strong
and localized expression of V1a mRNA in the AA and
CeA from Bregma −0.36 mm to –2.52 mm (Figures 7As).
To confirm this finding, we used another highly-sensitive
RNAscope ISH method, which allowed us to simultaneously
detect V1a mRNA together with Gad1 and Gad2 mRNA in
CeA. Figures 7B–D’s shows representative confocal images
under low and high magnification, illustrating the complete
co-localization of V1a mRNA with the Gad1 and Gad2 mRNA.
V1b and V2 probes for RNAscope, which gave positive signals
in anterior pituitary gland and renal tissues, did not yield
any positive labeling in the amygdaloidal complex (data not
shown).
Using immunohistochemistry, we observed AVPir+ fibers
surrounding the GABAir+ soma in the CeA (Figure 8A).
Figure 8Bs shows an example taken from CeA of a rat perfused
90 min after the EPM test from the group of MS/WD 24 h,
where all the GABAir+ neurons exhibited nuclear Fos expression,
a marker for neuronal activation, and also had membrane V1a
labeling.
AVP Infusion into CeA Induced
Anxiogenesis via a V1aR Pathway
To further evaluate the effect on anxiety of increased vasopressin
levels in amygdala, vasopressin (1 ng), vasopressin ((1 ng) +
the vasopressin V1a receptor antagonist Manning compound
(10 ng)) or vehicle (NaCl 0.9%) was infused at each of two
sites 15 min before the EPM test, via cannulas stereotaxically
placed in the CeA (Figure 9A). One-way ANOVA showed
that the differences between means were statistically significant
(p < 0.0001, F(2,32) = 15). Post hoc Bonferroni’s multiple
comparisons test showed that vasopressin infusion significantly
(p < 0.001) diminished the percentage of time spent in the
open arms (12.38% ± 1.48%) with respect to the vehicle group
(24.33% ± 1.16%). The AVP + V1a antagonist group showed a
significant increase in this value (29.75% ± 3.51%) with respect
to the AVP group (p< 0.01) and was no different than the vehicle
treated group (Figure 9B).
Vasopressin Infusion Enhanced the
Neuronal Activation in CeA and BLA After
the EPM
To evaluate the effect of the infusion of vasopressin, vasopressin
+ the V1a receptor antagonist (Manning compound) or vehicle
in the number of neurons activated by the EPM in the CeA, BLA
and MeA, we perfused the rats 90 min after finishing the EPM
test, sliced the brains, and performed immunohistochemistry
against c-Fos. Five brains, in which correct cannula placement
in CeA was confirmed, were selected to count the number
of Fos+ nuclei in an area of 0.2 mm2, inside the CeA, BLA
and MeA in 5–6 slices around the injection site (Figure 9C).
Panels (D–F) and inserts of Figure 9 show examples of these
immunoreactions in the vehicle, AVP and AVP + V1a antagonist
treated rats.
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FIGURE 7 | AVP receptor V1a mRNA expression in GABAergic neurons in the CeA. Panel (A’s) sequential coronal sections were hybridized with antisense
radioactive AVP V1a riboprobe. Autoradiographs with overnight-exposure were read by phosphorimager. Rostro-caudal coordinates were indicated according to Rat
Brain Atlas (Paxinos and Watson, 2006). AA, Anterior amygdala; CeA, central amygdala. (B–D) In situ hybridization using RNAscope-multiplex method targeting the
Gad-1, Gad-2 and V1a mRNAs in CeA. V1a mRNA is particularly expressed by Gad-1 and Gad-2 positive neurons. (B) Low magnification showing the selective
location of Gad1 + Gad2 expressing cell population in the CeA (dash-line circumscribed region). (C) Further magnifications showing the exclusive expression of V1a
mRNA in Gad1 and Gad2 positive cells (100%, n = 98 neurons analyzed). Optical section thickness 1 µm. (D’s) Confocal 1 µm optical slice of two cells in CeA
expressing Gad1 (red), Gad2 (green) and V1a receptor (white) mRNA. Using the same method for V1b mRNA, we did not find any positive labeling. This data is not
shown. The positive control for this latter experiment was done using adenohypophysis tissue. Scale bars: (B) 100 mm; (C) 20 µm; (D) 10 µm.
Frontiers in Neural Circuits | www.frontiersin.org 14 November 2016 | Volume 10 | Article 92
Hernández et al. Vasopressinergic Modulation of CeA GABAergic Neurons
FIGURE 8 | AVP containing fibers in CeA synapse upon V1a receptor-positive GABAergic neurons activated after EPM. (A) Immunohistochemistry
against AVP (arrowheads) and GABA (arrow) showing punctate AVP fibers terminals in close apposition with the GABA-labeled soma. (B) Confocal image of CeA
immunoreacted against FOS (red nuclei indicated by arrows); V1a receptor (red punctuated label, indicated by arrowheads) and GABA (green cells). The
immunohistochemistry was performed 90 min after the EPM in an animal infused with vasopressin in the CeA. (Ba) A different optical section of the same region
showing two GABA+ neurons, one of them negative for V1a receptor showing no expression of Fos, the other one expressing the V1a receptor being Fos+. Scale
bars: 10 µm.
Using a two-way ANOVA analysis (factors: region and
treatment), we observed a significant effect for region:
F(2,225) = 28.9, p < 0.0001; treatment: F(2,225) = 285.5,
p < 0.001 and their interaction: F(4,225) = 67.2, p < 0.001.
Tukey’s multiple comparisons test showed significant differences
in the CeA between the vehicle and AVP infused groups:
F(2,225) = 27.95, p< 0.001 and between the AVP and AVP + V1a
antagonist: F(2,225) = 24.68, p < 0.001; no difference between
vehicle and AVP + V1a antagonist was found: F(2,225) = 0.035,
p > 0.05. In the BLA region a similar pattern was found, with
significant differences between the vehicle and AVP infused
groups: F(2,225) = 21.26, p < 0.001 and between the AVP
and AVP + V1a antagonist: F(2,225) = 18.07, p < 0.001; no
difference between vehicle and AVP + V1a antagonist was
found: F(2,225) = 0.75, p > 0.05. With respect to the MeA, no
significant differences were found between any of the treatment
groups.
DISCUSSION
In this study, we investigated vasopressinergic innervation of
the rat amygdaloid complex, and its functional implications.
We quantified the density of AVP innervation in the subnuclei
of the amygdaloid complex and demonstrated that in parallel
to the AVP containing neurons in the STIA, previously
described (Caffé and van Leeuwen, 1983; Plumari et al.,
2002; Rood and De Vries, 2011), which are likely to be
GABAergic neurons (Dabrowska et al., 2013), there exist a
direct AVP-containing glutamatergic pathway, from VPMNN
axon collaterals, synaptically targeting the CeA. We report that
early life stress (MS) increased the density, and altered the
pattern, of AVP innervation to amygdala in agreement with
the enlarged PVN and SON previously reported (Zhang et al.,
2012). In CeA, mRNA encoding the V1a receptor was detected
as highly expressed and, using the newly developed RNAscope
method, we could demonstrate that all the cells expressing V1a
mRNA in CeA were Gad1- and Gad2-expressing cells. Using
immunohistochemistry, we observed that GABAergic neurons
inside the CeA expressed V1a receptor protein on their plasma
membrane. Physiological up-regulation of the VPMNN system
by WD 24 was associated with higher expression of anxiety-like
behavior, and increased Fos expression in the CeA,mainly within
GABA-positive neurons. The effects of WD 24 were mimicked
by AVP local micro-infusion into the CeA, and these effects,
and those of WD 24 itself, were attenuated by local infusion of
Manning compound a V1a receptor specific antagonist-into the
CeA.
A significant body of literature implicates AVP as a
transmitter subserving stress responses in adult rodents without
a history of stressor exposure, and in adult rodents with a
history of stressor exposure during early post-natal life (Veenema
and Neumann, 2008; Zhang et al., 2010, 2012, 2016; Zhang
and Hernández, 2013; Hernández et al., 2015). A potential
linkage between these two AVP-related types of stress response
is found in the observations that early-life stress, in rats, leads to
reorganization of vasopressinergic neurons of the PVN (Zhang
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FIGURE 9 | Altered anxious behavior and Fos expression after AVP infusion into CeA in AFR rats and reversal by co-infusion of V1a antagonist
(Manning compound). (A) Upper panel depicts positioning of cannulae in CeA for infusion of vehicle, AVP, or AVP plus V1a antagonist (Manning compound); lower
panel is a representative photomicrograph showing the trajectory of the cannula toward the CeA. (B) Bar graph showing the time spent in the open arms of the EPM
in animals infused bilaterally with vehicle (NaCl 0.9%), AVP or AVP + V1a antagonist (Manning compound). Infusion of AVP into CeA produced anxiety-like behavior
shown as a reduction of the time spent in the open arms (∗∗p < 0.01, ∗∗∗p < 0.001) compared with vehicle-treated rats. Infusion of AVP + V1a antagonist reversed
anxious behavior (decreased time spent in open arms) to control levels (i.e., indistinguishable from vehicle-treated rats). (C) Bar graph showing the quantification of
neurons activated (measured by Fos expression) after EPM in the CeA, BLA and MeA in vehicle, AVP, or AVP plus V1a antagonist infused groups. AVP produced a
significant increase in the Fos expression in the central (CeA, p < 0.001) and basolateral nuclei (BLA, p < 0.001) that was blunted in the AVP + V1a antagonist
group. No effect of the treatments was observed in the MeA. (D–F) Photomicrographs showing the Fos expression patterns seen in the three infusion groups after
the EPM, (Da–Fa) are magnifications of the squared regions in (D–F). BLA, basolateral amygdala; CeA, central amygdala; MeA, medial amygdala. Scale Bars:
(D–F) 1 mm; (Da–Fa) 0.1 mm.
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et al., 2012). However, an anatomical connection between effects
of AVP on behavioral responses to stress, mainly associated
with AVP receptors resident in the amygdala, and specific
projections from paraventricular VPMNNs, has not yet been
made. As we have previously identified axonal projections
from VPMNNs to various extrahypothalamic brain regions
(Hernández et al., 2015), including those putatively involved
in stress responding (Zhang and Hernández, 2013; Zhang
et al., 2016), we hypothesized that VPMNN projections to the
amygdala might modulate both adult stress/anxiogenic circuits,
and provide an anatomical substrate for adult stress response
conditioning occurring during the neonatal period. Accordingly,
we designed and carried out a functional neuroanatomical
study of AVP VPMNNs projections to amygdala, their putative
neurons of origin, and the potential role of these AVP
neurons in stress response modulation in both acute adult, and
developmentally determined, behavior contexts.
In brief (vida supra), our data suggest that vasopressinergic
projections, originating from magnocellular soma of the PVN
(VPMNNs), synapse uponGABAergic neurons of the CeAwhich
contain V1a receptors; that the CeA projections of these neurons
are increased by early-life stress (MS); that activation of these
neurons via WD in adulthood is anxiogenic; that the degree of
anxiogenesis is correlated with the number and AVP content
of these projections; and that anxiogenesis correlated with the
dynamic changes of VPMNN system projecting to the CeA can
be mimicked by CeA infusion of AVP, and blocked by CeA
infusion of a V1a antagonist. What are the implications of these
findings?
First, the localization of AVP-dependent stress responding
to VPMNNs of the PVN, in both adult stress responding
and in developmental shaping of the stress response, allows
the testing of further important hypotheses about the
amygdalar microcircuitry of stress, and the extent of AVP
involvement in this circuitry. Thus, we may now hypothesize
that the locus of action, or at least one anatomical target,
of psychogenic stressors such as MS in early life, that affect
long-term neuroplasticity of the VPMNN population, is at
synapses on GABAergic neurons of the CeA. It is noteworthy
that MS does not cause increased adult anxious behavior
on its own, but rather increases the penetrance of other
stressors (thirst, this study; electrical shock in previous
studies—see Zhang et al., 2012) in a way that requires AVP
transmission within the CeA. Examination of the corresponding
dependence on AVP release within the CeA, as probed
with local infusion of V1A antagonist, of other adult and
anxiogenic stressors, including restraint, social defeat, and
social subordination, appears highly warranted by the results
presented here.
Second, the localization to GABAergic neurons of CeA
of these vasopressinergic effects on stress responding
raises the important question of where these circuits
ultimately find expression in altered exploratory and other
anxiety-associated behaviors in the rodent. The recent expansion
of detailed knowledge about GABAergic neurons in CeA
involved in mediating the salience of negative (fear- and
anxiety-inducing) environmental stimuli now allows more
anatomically detailed inquiry into the precise role of VPMNN
projections in this circuitry (for example see Haubensak et al.,
2010).
Finally, this work exposes a new opportunity to test the
relative specificities of various neuropeptides in modulation of
the stress response. The metabolic activation of VPMNNs
following 24 h of thirst is itself a stressor, but a very
specific paraphysiological one, that has allowed a clear
linkage between VPMNN activation and anxiogenesis to
be revealed (vide supra). However this work also allows
the testing of AVP and VPMNN dependence of behavioral
responses to other stressors, as well as exploring whether
or not AVP release onto GABAergic synapses in CeA is
a general feature of amygdala-mediated modulation of
emotional responses to stress, or is reserved to specific
subtypes of stress responding, with other neuropeptides
mediating different and equally specific modes of stress response
modulation.
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